옵션
AI 프롬프트 목록 철학/종교 윤리적 의사결정 지원

윤리적 의사결정 지원

{:__('collect %s',윤리적 의사결정 지원)}

공리주의와 의무론의 틀을 사용하여 복잡한 비즈니스 결정의 도덕적 영향을 평가하고, 규정 준수 및 사회적 가치가 있는 행동 계획을 생성합니다.

프롬프트 내용 복사 복사

Act as a senior corporate ethics consultant to deeply analyze the current business decision dilemma using a dual framework of utilitarianism and deontology. First, identify key stakeholders involved and their potential rights infringements, then evaluate the balance between long-term social impacts and short-term commercial benefits of different action plans. Avoid simple binary judgments; instead, provide a structured ethical risk assessment report pointing out potential moral pitfalls and offering optimization suggestions that align with corporate social responsibility standards, ensuring the final plan pursues profit without violating basic human values and legal bottom lines.

복사 복사

시니어 기업 윤리 고문으로서 공리주의와 의무론의 이중 틀을 사용하여 현재 비즈니스 결정의 딜레마를 깊이 분석하십시오. 먼저 관여하는 주요 이해관계자와 그들의 잠재적 권리 침해를 식별한 다음, 다양한 행동 계획의 장기적 사회적 영향과 단기적 상업적 이익의 균형을 평가하십시오. 단순한 이분법적 판단을 피하고, 잠재적인 도덕적 함정을 지적하며 기업 사회적 책임 기준에 부합하는 최적화 제안을 제공하는 구조화된 윤리 위험 평가 보고서를 작성하십시오. 최종 계획이 이익을 추구하면서도 기본적 인간 가치와 법적 한계를 위반하지 않도록 보장하십시오.

복사 복사
의견 (0)
0/300

추천

윤리적 의사결정 지원
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers minor but non-fatal side effects during clinical trials that may affect long-term patient quality of life, yet the drug can save thousands of lives with no alternatives. Combine the utilitarian principle of maximizing happiness with the deontological principle of respecting life to analyze whether clinical trials should proceed, and provide balanced advice considering legal compliance, public trust, and patient rights, avoiding absolute moral judgments in favor of a stakeholder-based decision path.
윤리적 의사결정 지원
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug discovers minor but long-term side effects in clinical trials, while a competitor is about to launch a similar product. Please evaluate whether to disclose data early and delay launch by balancing utilitarian considerations of the greatest good for the greatest number against deontological duties regarding patient informed consent and corporate integrity. Provide a comprehensive report including risk assessment, stakeholder impact analysis, and final action recommendations, ensuring the decision aligns with legal compliance while reflecting the company's social responsibility and long-term values.
윤리적 의사결정 지원
Act as a senior corporate ethics consultant to conduct a deep moral assessment of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please analyze the trade-offs between disclosing information, adjusting pricing, developing alternatives, and assuming social responsibility by integrating utilitarian impacts on overall well-being with deontological respect for patient autonomy and the principle of non-maleficence. Provide a comprehensive action plan that balances commercial sustainability with moral integrity, focusing on how to protect patient rights while ensuring the company's long-term viability.
윤리적 의사결정 지원
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks with long-term use, but recalling it would lead to bankruptcy and affect thousands of employees' livelihoods, while concealing it violates patient safety principles. Please evaluate the moral weight of three options—public disclosure, partial recall, or complete concealment—by combining the utilitarian view of the greatest happiness for the greatest number with the deontological view of respecting individual rights and the duty of honesty, and provide a specific action recommendation that balances social responsibility and corporate survival, ensuring the decision-making process is transparent and compliant with business ethics norms.
윤리적 의사결정 지원
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.
윤리적 의사결정 지원
Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.
OR